125,749 Shares in Cardinal Health, Inc. $CAH Acquired by Manning & Napier Advisors LLC

Manning & Napier Advisors LLC purchased a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 125,749 shares of the company’s stock, valued at approximately $29,873,000. Manning & Napier Advisors LLC owned approximately 0.05% of Cardinal Health at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CAH. L2 Asset Management LLC acquired a new stake in shares of Cardinal Health in the second quarter worth $8,716,000. Vega Investment Solutions acquired a new position in Cardinal Health in the 2nd quarter valued at $3,412,000. Trail Ridge Investment Advisors LLC bought a new position in Cardinal Health in the 2nd quarter worth $1,776,000. Algert Global LLC raised its holdings in Cardinal Health by 246.9% in the 2nd quarter. Algert Global LLC now owns 36,993 shares of the company’s stock worth $8,788,000 after acquiring an additional 26,330 shares during the period. Finally, Cibc World Market Inc. bought a new stake in Cardinal Health during the second quarter valued at about $9,427,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Up 1.1%

NYSE CAH opened at $232.13 on Tuesday. The stock’s 50 day moving average is $232.13 and its two-hundred day moving average is $217.96. Cardinal Health, Inc. has a 1-year low of $145.87 and a 1-year high of $258.30. The company has a market capitalization of $53.99 billion, a price-to-earnings ratio of 32.11, a PEG ratio of 1.23 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The company had revenue of $63.67 billion during the quarter, compared to analysts’ expectations of $65.15 billion. During the same period last year, the business earned $2.08 earnings per share. The business’s revenue was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, analysts predict that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be paid a $0.5158 dividend. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s payout ratio is 28.49%.

Analysts Set New Price Targets

CAH has been the topic of several research analyst reports. Citigroup raised their price target on Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. William Blair began coverage on Cardinal Health in a research note on Tuesday, April 28th. They set an “outperform” rating for the company. Royal Bank Of Canada assumed coverage on Cardinal Health in a report on Wednesday, August 19th. They issued an “outperform” rating and a $276.00 target price on the stock. Robert W. Baird upped their price target on Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a report on Wednesday, August 12th. Finally, Morgan Stanley increased their price objective on Cardinal Health from $255.00 to $265.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $266.56.

Cardinal Health News Roundup

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health’s specialty business remains a key growth driver, supporting the case for retaining CAH in portfolios. The company has also issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, broadly consistent with analyst expectations. Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
• Positive Sentiment: Recent coverage highlights Cardinal Health’s efforts to expand its healthcare reach, potentially creating additional growth opportunities beyond its core pharmaceutical distribution operations. Why Is Cardinal Health Expanding Its Healthcare Reach?
• Positive Sentiment: Cardinal Health’s latest quarterly results provided support for the stock: earnings per share exceeded consensus estimates, while revenue increased year over year. The company’s medical and pharmaceutical services also remain central to its relative performance within the healthcare providers and services group. Winners and Losers of Q2: Cardinal Health vs. Healthcare Providers and Services Stocks

Insider Buying and Selling

In other news, CEO Jason M. Hollar sold 80,000 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $235.74, for a total value of $18,859,200.00. Following the completion of the sale, the chief executive officer directly owned 235,132 shares in the company, valued at approximately $55,430,017.68. This trade represents a 25.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Deborah Weitzman sold 7,354 shares of the company’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the transaction, the chief executive officer owned 77,901 shares in the company, valued at approximately $18,341,790.45. This trade represents a 8.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 210,271 shares of company stock valued at $49,626,657 in the last ninety days. 0.12% of the stock is owned by corporate insiders.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.